Latest news

News archive

CEO Comment Q4 2022

FOCUS ON PRODUCTION A continued focus on production has characterized both the fourth quarter and the beginning of the new year. At the same time, our view of the market needs for additional suppliers of high-quality silica for preparative chromatography was strengthened. During the fourth quarter, our main focus has continued to be on production. We manufacture silica on a large scale and as we previously have described, we are satisfied with our product, but

Read more »

Nanologica’s Year-End Report 2022

FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 674 (676) and for the full year to TSEK 1,555 (12,914) The operating loss for the quarter amounted to TSEK -13,251 (-14,108) and for the full year to TSEK -50,850 (-40,689) Loss after tax for the quarter amounted to TSEK -14,855 (-15,222) and for the full year to TSEK -55,231 (-44,829) Earnings per share before and after dilution were SEK -0.42 (-0.54) for the

Read more »

Nanologicas bokslutskommuniké 2022

FINANSIELL SAMMANFATTNING Nettoomsättningen för fjärde kvartalet uppgick till 674 TSEK (676) och för helåret till 1 555 TSEK (12 914) Rörelseresultatet för kvartalet uppgick till -13 251 TSEK (-14 108) och för helåret till -50 850 TSEK (-40 689) Resultatet efter skatt för kvartalet uppgick till -14 855 TSEK (-15 222) och för helåret till -55 231 TSEK (-44 829) Resultat per aktie före och efter utspädning var -0,42 SEK (-0,54) för kvartalet och för

Read more »